Bilal Piperdi, MD | Authors

Articles

Molecular Targeted Agents for Stage III NSCLC

November 15, 2013

Bilal Piperdi, MD, Associate Professor of Clinical Medicine, Department of Medicine (Oncology), Albert Einstein College of Medicine, comments on molecular targeted agents for stage III non-small cell lung cancer (NSCLC).